Recent Updates
Recently added Catalysts
COCH Positive Sentiment

Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th

Key Takeaway: Envoy Medical has rescheduled its third quarter 2026 earnings call to 8:00 A.M. ET on November 5, 2026. The company will release its financial results before the market opens on the same day. Interested individuals can join the live call or access a replay until November 19, 2026.

Market Sentiment Analysis

POSITIVE FACTORS

  • Company reports financial results before market opens.
  • Conference call scheduled for November 5, 2026.
  • Replay available for interested participants.

Full Press Release Details

Financial Results to Be Released Before Market Open
White Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company") , a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has updated the time of its conference call to discuss financial results for the third quarter ended September 30, 2026. The conference call will now be held at 8:00 A.M. ET on Thursday, November 5, 2026. The Company will report its third quarter financial results before the market opens on the same day.
Third Quarter 2026 Financial Results Conference Call: Date: Thursday, November 5, 2026 Time: 8:00 A.M. ET Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International) Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1778210&tp_key=20071611a1
For interested individuals unable to join the conference call, a replay will be available through November 19, 2026, by dialing 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11162715.
To be added to the Envoy Medical email distribution list, please email Envoy@kcsa.com with COCH in the subject line.
About Envoy Medical, Inc. Envoy Medical (NASDAQ: COCH) is a hearing health and neuroprosthetics company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life.
Investor Contact: Phil Carlson KCSA Strategic Communications O: 212.896.1233 E: Envoy@kcsa.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321373
Released October 28, 2026

Frequently Asked Questions

When is the Envoy Medical Q3 2026 earnings call?

The earnings call is scheduled for 8:00 A.M. ET on November 5, 2026.

How can I join the Envoy Medical earnings call?

You can join by calling 1-800-267-6316 for U.S. or 1-203-518-9783 for international.

Will there be a replay of the earnings call?

Yes, a replay will be available until November 19, 2026.

What financial results will Envoy Medical report?

Envoy Medical will report its financial results for Q3 2026.

Last updated: Oct 28, 2026